Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C van der Poel

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The British Journal of Ophthalmology|December 1, 1986
Estimation of visual function after optic neuritis: a comparison of clinical testsE A Sanders, A C Volkers, J C van der Poel, et al.
Blood|April 16, 1998
Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole bloodE Gomez, S C van der Poel, J H Jansen, et al.
Annals of Hematology|August 1, 1994
Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet countP J van Genderen, J J Michiels, S C van der Poel-van de Luytgaarde, et al.
Transfusion|October 1, 1991
Risk factors in hepatitis C virus-infected blood donorsC van der Poel, H Cuypers, H Reesink, et al.
Vox Sanguinis|March 23, 1999
GB virus type C viremia and envelope antibodies among population subsets in The NetherlandsJ Jongerius, G Boland, C van der Poel, et al.
Neurology|February 1, 1988
Magnetic resonance imaging of the optic nerve in optic neuritisD H Miller, M R Newton, J C van der Poel, et al.
British Journal of Haematology|July 26, 2002
Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusionBert A van der Reijden, Annet Simons, Erna Luiten, et al.
Blood|December 24, 2010
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityErdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The British Journal of Ophthalmology|December 1, 1986
Estimation of visual function after optic neuritis: a comparison of clinical testsE A Sanders, A C Volkers, J C van der Poel, et al.
Blood|April 16, 1998
Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole bloodE Gomez, S C van der Poel, J H Jansen, et al.
Annals of Hematology|August 1, 1994
Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet countP J van Genderen, J J Michiels, S C van der Poel-van de Luytgaarde, et al.
Transfusion|October 1, 1991
Risk factors in hepatitis C virus-infected blood donorsC van der Poel, H Cuypers, H Reesink, et al.
Vox Sanguinis|March 23, 1999
GB virus type C viremia and envelope antibodies among population subsets in The NetherlandsJ Jongerius, G Boland, C van der Poel, et al.
Neurology|February 1, 1988
Magnetic resonance imaging of the optic nerve in optic neuritisD H Miller, M R Newton, J C van der Poel, et al.
British Journal of Haematology|July 26, 2002
Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusionBert A van der Reijden, Annet Simons, Erna Luiten, et al.
Blood|December 24, 2010
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityErdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, et al.
Pageof 2